Concert Pharmaceuticals CNCE Stock
Concert Pharmaceuticals Price Chart
Concert Pharmaceuticals CNCE Financial and Trading Overview
Concert Pharmaceuticals stock price | 8.37 USD |
Previous Close | 8.37 USD |
Open | 8.38 USD |
Bid | 0 USD x 1800 |
Ask | 0 USD x 21500 |
Day's Range | 8.35 - 8.55 USD |
52 Week Range | 2.72 - 8.55 USD |
Volume | 0 USD |
Avg. Volume | 2.64M USD |
Market Cap | 401.95M USD |
Beta (5Y Monthly) | 0.520519 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13 USD |
CNCE Valuation Measures
Enterprise Value | 265.92M USD |
Trailing P/E | N/A |
Forward P/E | -3.111524 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 12.544446 |
Price/Book (mrq) | 3.0107913 |
Enterprise Value/Revenue | 8.299 |
Enterprise Value/EBITDA | -2.922 |
Trading Information
Concert Pharmaceuticals Stock Price History
Beta (5Y Monthly) | 0.520519 |
52-Week Change | 116.27% |
S&P500 52-Week Change | -1.50% |
52 Week High | 8.55 USD |
52 Week Low | 2.72 USD |
50-Day Moving Average | 7.68 USD |
200-Day Moving Average | 6.05 USD |
CNCE Share Statistics
Avg. Volume (3 month) | 2.64M USD |
Avg. Daily Volume (10-Days) | 2.51M USD |
Shares Outstanding | 48.02M |
Float | 43.66M |
Short Ratio | 0.26 |
% Held by Insiders | 3.77% |
% Held by Institutions | 77.05% |
Shares Short | 1.08M |
Short % of Float | 2.43% |
Short % of Shares Outstanding | 2.23% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -287.96% |
Gross Margin | -220.52% |
EBITDA Margin | -284.011% |
Management Effectiveness
Return on Assets (ttm) | -38.52% |
Return on Equity (ttm) | -108.68% |
Income Statement
Revenue (ttm) | 32.04M USD |
Revenue Per Share (ttm) | 0.79 USD |
Quarterly Revenue Growth (yoy) | -98.50% |
Gross Profit (ttm) | -54977000 USD |
EBITDA | -91003000 USD |
Net Income Avi to Common (ttm) | -126682000 USD |
Diluted EPS (ttm) | -3.17 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 149.53M USD |
Total Cash Per Share (mrq) | 3.12 USD |
Total Debt (mrq) | 14.21M USD |
Total Debt/Equity (mrq) | 10.67 USD |
Current Ratio (mrq) | 9.035 |
Book Value Per Share (mrq) | 2.78 |
Cash Flow Statement
Operating Cash Flow (ttm) | -109663000 USD |
Levered Free Cash Flow (ttm) | -43797752 USD |
Profile of Concert Pharmaceuticals
Country | United States |
State | MA |
City | Lexington |
Address | 65 Hayden Avenue |
ZIP | 02421 |
Phone | 781 860 0045 |
Website | https://www.concertpharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 64 |
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
Q&A For Concert Pharmaceuticals Stock
What is a current CNCE stock price?
Concert Pharmaceuticals CNCE stock price today per share is 8.37 USD.
How to purchase Concert Pharmaceuticals stock?
You can buy CNCE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Concert Pharmaceuticals?
The stock symbol or ticker of Concert Pharmaceuticals is CNCE.
Which industry does the Concert Pharmaceuticals company belong to?
The Concert Pharmaceuticals industry is Biotechnology.
How many shares does Concert Pharmaceuticals have in circulation?
The max supply of Concert Pharmaceuticals shares is 0.
What is Concert Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Concert Pharmaceuticals PE Ratio is 0.00000000 now.
What was Concert Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Concert Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Concert Pharmaceuticals company belong to?
The Concert Pharmaceuticals sector is Healthcare.
Concert Pharmaceuticals CNCE included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
NASDAQ Global Market Composite NQGM | 1952.45 USD — |
-0.14
|
— — | 1922.5 USD — | 1956.75 USD — | — - | — — |
NASDAQ Biotechnology NBI | 4084.75 USD — |
+0.07
|
— — | 4033.52 USD — | 4091.93 USD — | — - | — — |
Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
NASDAQ Composite Total Return XCMP | 22955.12 USD — |
-0.99
|
— — | 22786.65 USD — | 23082.91 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
NASDAQ Biotechnology Total Retu XNBI | 4427.65 USD — |
+0.09
|
— — | 4372.13 USD — | 4435.43 USD — | — - | — — |
- {{ link.label }} {{link}}